EU Speedy Review Request For J&J’s Esketamine

Fast Track
EMA's accelerated assessment mechanism allows drug reviews within 150 days • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Review Pathways

More from Pathways & Standards